Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
GC-506 by Gracell Biotechnologies for Gastric Cancer: Likelihood of Approval
GC-506 is under clinical development by Gracell Biotechnologies and currently in Phase I for Gastric Cancer. According to GlobalData, Phase...